Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications ; volume:13 ; number:1 ; day:8 ; month:2 ; year:2012 ; pages:1-10 ; date:12.2012
BMC immunology ; 13, Heft 1 (8.2.2012), 1-10, 12.2012
- Urheber
-
Jimenez-Perez, Miriam I.
Jave-Suarez, Luis F.
Ortiz-Lazareno, Pablo C.
Bravo-Cuellar, Alejandro
Gonzalez-Ramella, Oscar
Aguilar-Lemarroy, Adriana
Hernandez-Flores, Georgina
Pereira-Suarez, Ana L.
Daneri-Navarro, Adrian
del Toro-Arreola, Susana
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1471-2172-13-7
- URN
-
urn:nbn:de:101:1-2021080921323589212439
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
2025-08-14T10:45:35+0200
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jimenez-Perez, Miriam I.
- Jave-Suarez, Luis F.
- Ortiz-Lazareno, Pablo C.
- Bravo-Cuellar, Alejandro
- Gonzalez-Ramella, Oscar
- Aguilar-Lemarroy, Adriana
- Hernandez-Flores, Georgina
- Pereira-Suarez, Ana L.
- Daneri-Navarro, Adrian
- del Toro-Arreola, Susana
- SpringerLink (Online service)
Ähnliche Objekte (12)
T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells
Targeting senescent cells with NKG2D-CAR T cells
Proteolytic shedding of NKG2D ligands from tumour cells : = Proteolytische Freisetzung von NKG2D-Liganden durch Tumorzellen
Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D/NKG2D-L pathway to kill CML cells with or without T315I mutation
Immunregulatorische Effekte von NKG2D-Liganden
NKG2D signaling certifies effector CD8 T cells for memory formation
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
Cutting an NKG2D ligand short : cellular processing of the peculiar human NKG2D ligand ULBP4
TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
Regulation of immune cell function and differentiation by the NKG2D receptor
Analysis of immune-modulatory effects of NKG2D ligands on T cells
T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells
Targeting senescent cells with NKG2D-CAR T cells
Proteolytic shedding of NKG2D ligands from tumour cells : = Proteolytische Freisetzung von NKG2D-Liganden durch Tumorzellen
Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D/NKG2D-L pathway to kill CML cells with or without T315I mutation
Immunregulatorische Effekte von NKG2D-Liganden
NKG2D signaling certifies effector CD8 T cells for memory formation
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
Cutting an NKG2D ligand short : cellular processing of the peculiar human NKG2D ligand ULBP4
TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
Regulation of immune cell function and differentiation by the NKG2D receptor
Analysis of immune-modulatory effects of NKG2D ligands on T cells
T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells
Targeting senescent cells with NKG2D-CAR T cells
Proteolytic shedding of NKG2D ligands from tumour cells : = Proteolytische Freisetzung von NKG2D-Liganden durch Tumorzellen
Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D/NKG2D-L pathway to kill CML cells with or without T315I mutation
Immunregulatorische Effekte von NKG2D-Liganden
NKG2D signaling certifies effector CD8 T cells for memory formation
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
Cutting an NKG2D ligand short : cellular processing of the peculiar human NKG2D ligand ULBP4
TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
Regulation of immune cell function and differentiation by the NKG2D receptor